Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

TScan Therapeutics
830 Winter St.
Waltham, MA 02451
Phone: 857-399-9500
https://www.tscan.com/

TScan designs therapies that reprogram a patient\'s own T cells to recognize and fight their cancer using naturally occurring TCRs that recognize shared cancer targets. The TScan discovery process is a proprietary genome-wide, high-throughput target identification screen, designed to rapidly identify the natural targets of TCRs. TScan is developing a portfolio of TCR therapies for patients suffering from both liquid and solid tumors.

Key Contact
Name
David Southwell
Title
CEO
Funding Events

Date
Amount
Type
Investors
07/24/19 $48,000,000 Series B Bessemer Venture Partners
Google Ventures
Longwood Fund
Novartis Institute for Biomedical Research
Novartis Venture Funds
01/09/20 undisclosed Series B Astellas Venture Management
Novartis Institute for Biomedical Research
Pitango Venture Capital
01/25/21 $100,000,000 Series C 6 Dimensions Capital
Bessemer Venture Partners
BlackRock
GV
Longwood Fund
Novartis Venture Funds
Pitango Venture Capital
RA Capital Management


Featured Reading